Zinc supplementation and chronic pelvic pain syndrome
Phase 2
- Conditions
- Chronic pelvic pain syndrome.Pelvic and perineal painR10.2
- Registration Number
- IRCT20210614051574N12
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age between 18-65 years
Diagnosis of chronic pelvic pain syndrome by a urologist
Absence of underlying disease
Free and informed written consent
Exclusion Criteria
Failure to take medication regularly
Drug intolerance
Taking zinc supplements during the last 3 months
Tendency to leave during the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: Before and after two weeks and one month after interventions. Method of measurement: Visual analog scale.;Chronic pelvic pain. Timepoint: Before and after two weeks and one month after interventions. Method of measurement: Chronic Prostatitis Symptom Index (NIH-CPSI).
- Secondary Outcome Measures
Name Time Method